目的:本研究旨在确定幼儿良性阵发性位置性眩晕(BPPV)的临床特征。
方法:回顾性病例回顾。
方法:选择2012年12月至2021年7月在我们的儿科前庭项目中诊断为BPPV的所有<10岁儿童。通过病历审查确定临床特征,包括人口统计,合并症,运河介入,对治疗的反应,和复发的发生率。
结果:共有34名儿童被诊断为BPPV,诊断时平均年龄7.9岁(SD±1/7;范围5-9),男女比例为1:1。涉及的半规管包括后部的82%(n=28),水平在41%(n=14),在24%(n=8)的患者中,分别。共病诊断包括偏头痛(n=14),脑震荡(n=10),急性前庭综合征(n=4),和持续的姿势知觉头晕(n=6)。10例患者(29%)发生了最初确认的复发,平均每位患者复发2.5例(SD:2.2;范围1-8)。11例和17例患者均有眩晕或偏头痛家族史,分别。
结论:BPPV是儿童眩晕的一个原因,可能被忽视。相对较高比例的患者表现出水平或上管受累,复发,以及头晕的其他合并症原因。因此,评估患有头晕的幼儿的提供者应进行诊断操作,以评估所有半规管的BPPV,并在成功治疗后继续监测儿童的复发.
方法:4,病例系列喉镜,133:694-699,2023年。
This study aimed to determine the clinical characteristics of benign paroxysmal positional vertigo (BPPV) in young children.
Retrospective case review.
All children <10 years old that have been diagnosed with BPPV at our pediatric vestibular program between December 2012-July 2021 were selected. Clinical features were identified by medical record review, including demographics, comorbidities, canal involvement, response to treatment, and incidence of recurrence.
A total of 34 children were diagnosed with BPPV with a mean age of 7.9 years old (SD ± 1/7; range 5-9) at the time of diagnosis and a male:female ratio of 1:1. Involved semicircular canals included posterior in 82% (n = 28), horizontal in 41% (n = 14), and superior in 24% (n = 8) of patients, respectively. Comorbid diagnoses included migraine (n = 14), concussion (n = 10), acute vestibular syndrome (n = 4), and persistent postural perceptual dizziness (n = 6). Recurrence with initially confirmed resolution occurred in 10 patients (29%) with a mean of 2.5 recurrences per patient (SD: 2.2; range 1-8). A family history of vertigo or migraine was identified in 11 and 17 patients, respectively.
BPPV is a cause of vertigo in children that may be overlooked. A relatively high proportion of patients demonstrated horizontal or superior canal involvement, recurrence, and additional comorbid causes of dizziness. Thus, providers evaluating young children with dizziness should perform diagnostic maneuvers to evaluate BPPV of all semicircular canals and continue to monitor children after successful treatment for recurrence.
4, Case Series Laryngoscope, 133:694-699, 2023.